RheumMadness is an online tournament in which a bracket of teams, representing key learning concepts in rheumatology, compete against each other in a series of head-to-head matchups, much like basketball teams in the NCAA’s March Madness. The 2023 tournament theme was The All Star Season. Each team represented one all star article competing to be…
Search results for: hip OA
William ‘Will’ F. Harvey, MD, MSc, FACR, Joins ACR Executive Committee as Secretary
Stepping into the role of ACR secretary, William F. Harvey, MD, MSc, FACR, will pursue member engagement and corporate relations priorities, building on his long history of volunteer work in the College.
Ignite the Spark of Joy & Discovery
A Roshi (i.e., master) apparently said that in Zen, “there is nothing to believe and everything to discover.” Interestingly enough, I have never been able to confirm who actually said that, which makes this saying about belief and discovery particularly apt. Regardless, I think about those words at least twice a day when I am…
Rheumatologists Treat Patients While Ukraine Is at War
Rheumatologists living in Ukraine press on with their work of treating patients despite the ongoing war that began with a Russian military invasion.
In Memoriam: Rodanthi Kitridou, a Titan of Rheumatology
Dr. Rodanthi Kitridou is fondly remembered by a mentee as a trailblazer and role model.
In Memoriam: The Far-Reaching Legacy of Naomi Rothfield, MD, MACR
A tribute to the life and distinguished career of Naomi Rothfield, MD, MACR.
ACR White Paper, Position Statement Address Rheumatology’s Benefits
A new white paper and position statement from the ACR address the clinical and economic value of rheumatology, including patient outcomes and healthcare cost savings.
2024 Proposed Rule for the Quality Payment Program Released
See key changes for the Merit-Based Incentive Payment System for the 2024 performance year as outlined in the proposed rule.
A Novel Study Compared the Effectiveness of Adalimumab with Tofacitinib in RA
Your patient with rheumatoid arthritis (RA) isn’t responding well enough to methotrexate, and you both agree it’s time to consider a biologic or targeted synthetic disease-modifying anti-rheumatic drug (DMARD). But which one should you choose? In a treat-to-target era, we’re fortunate to have a variety of RA therapies at our disposal. Clinical practice guidelines from…
Ethics Forum: Thoughts on Managing Electronic Communication with Patients
Recent proposals in the U.S. to bill for electronic communication with our patients could be seen as a refreshing but contested attempt to battle burnout rates in the present era. A fee for electronic communications between patients and clinicians also acknowledges the value of the clinician’s time and expertise. But is this ethical? Discussion Burnout…
- « Previous Page
- 1
- …
- 53
- 54
- 55
- 56
- 57
- …
- 323
- Next Page »